Pseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent
Viruses · 13.02.2023 · 15 (2) · 520
DOI: 10.3390/v15020520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 13.02.2023. Verfasst von Fatma Abdelrahman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Microbiology and Phage Therapy, Zewail City of Science and Technology, 6th of October City 12578, Egypt. Hauptthemen laut MEDLINE: Pseudomonas Phages, Bacteriophages. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Govt. of India, Egyptian Sciences and Technology Development Fund (STDF).
Abstract (Originalsprache)
The challenge of antibiotic resistance has gained much attention in recent years due to the rapid emergence of resistant bacteria infecting humans and risking industries. Thus, alternatives to antibiotics are being actively searched for. In this regard, bacteriophages and their enzymes, such as endolysins, are a very attractive alternative. Endolysins are the lytic enzymes, which are produced during the late phase of the lytic bacteriophage replication cycle to target the bacterial cell walls for progeny release. Here, we cloned, expressed, and purified LysZC1 endolysin from Pseudomonas phage ZCPS1. The structural alignment, molecular dynamic simulation, and CD studies suggested LysZC1 to be majorly helical, which is highly similar to various phage-encoded lysozymes with glycoside hydrolase activity. Our endpoint turbidity reduction assay displayed the lytic activity against various Gram-positive and Gram-negative pathogens. Although in synergism with EDTA, LysZC1 demonstrated significant activity against Gram-negative pathogens, it demonstrated the highest activity against Bacillus cereus. Moreover, LysZC1 was able to reduce the numbers of logarithmic-phase B. cereus by more than 2 log10 CFU/mL in 1 h and also acted on the stationary-phase culture. Remarkably, LysZC1 presented exceptional thermal stability, pH tolerance, and storage conditions, as it maintained the antibacterial activity against its host after nearly one year of storage at 4 °C and after being heated at temperatures as high as 100 °C for 10 min. Our data suggest that LysZC1 is a potential candidate as a therapeutic agent against bacterial infection and an antibacterial bio-control tool in food preservation technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Microbiology and Phage Therapy, Zewail City of Science and Technology, 6th of October City 12578, Egypt.
- Microbiology and Molecular Biology Laboratory, Indian Institute of Science Education and Research, Bhopal 462066, India.
- Department of Microbiology and Botany, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
- Faculty of Environmental Agricultural Sciences, Arish University, Arish 45511, Egypt.
ORCID-Profile: Fatma Abdelrahman, Ayman El-Shibiny
Förderung
- Department of Science and Technology, Govt. of India
- Egyptian Sciences and Technology Development Fund (STDF)
Zitieren
APA
Abdelrahman, F., Gangakhedkar, R., Nair, G., El-Didamony, G., Askora, A., Jain, V., & El-Shibiny, A. (2023). Pseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent. Viruses, 15(2), 520. https://doi.org/10.3390/v15020520
Vancouver
Abdelrahman F, Gangakhedkar R, Nair G, El-Didamony G, Askora A, Jain V, et al. Pseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent. Viruses. 2023;15(2):520. doi:10.3390/v15020520
BibTeX
@article{Abdelrahman2023,
author = {Abdelrahman, Fatma and Gangakhedkar, Rutuja and Nair, Gokul and El-Didamony, Gamal and Askora, Ahmed and Jain, Vikas and El-Shibiny, Ayman},
title = {Pseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent},
journal = {Viruses},
year = {2023},
volume = {15},
number = {2},
pages = {520},
doi = {10.3390/v15020520}
}
EUVIMED